CA2119780A1 - 11.beta.-substituted 14,17-ethanoestratrienes, process for preparing these compounds and their use for preparing medicaments - Google Patents

11.beta.-substituted 14,17-ethanoestratrienes, process for preparing these compounds and their use for preparing medicaments

Info

Publication number
CA2119780A1
CA2119780A1 CA002119780A CA2119780A CA2119780A1 CA 2119780 A1 CA2119780 A1 CA 2119780A1 CA 002119780 A CA002119780 A CA 002119780A CA 2119780 A CA2119780 A CA 2119780A CA 2119780 A1 CA2119780 A1 CA 2119780A1
Authority
CA
Canada
Prior art keywords
ethano
acid
methyl
amide
trien
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002119780A
Other languages
English (en)
French (fr)
Inventor
Rolf Bohlmann
Hermann Kunzer
Hans-Peter Muhn-Seipoldy
Yukishige Nishino
Martin Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of CA2119780A1 publication Critical patent/CA2119780A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
CA002119780A 1991-09-24 1992-09-24 11.beta.-substituted 14,17-ethanoestratrienes, process for preparing these compounds and their use for preparing medicaments Abandoned CA2119780A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4132182A DE4132182A1 (de) 1991-09-24 1991-09-24 11(beta)-substituierte 14, 17-ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
DEP4132182.0 1991-09-24

Publications (1)

Publication Number Publication Date
CA2119780A1 true CA2119780A1 (en) 1993-04-01

Family

ID=6441613

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002119780A Abandoned CA2119780A1 (en) 1991-09-24 1992-09-24 11.beta.-substituted 14,17-ethanoestratrienes, process for preparing these compounds and their use for preparing medicaments

Country Status (10)

Country Link
US (1) US5502046A (enExample)
EP (2) EP0546591A2 (enExample)
JP (1) JPH07501792A (enExample)
AT (1) ATE146185T1 (enExample)
CA (1) CA2119780A1 (enExample)
DE (2) DE4132182A1 (enExample)
DK (1) DK0642529T3 (enExample)
ES (1) ES2097924T3 (enExample)
GR (1) GR3022692T3 (enExample)
WO (1) WO1993006124A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19724187A1 (de) * 1997-06-02 1998-12-03 Schering Ag 11beta-Arylsubstituierte 14,17-Ethanoestratriene, Verfahren zur Herstellung dieser Verbindungen, sowie ihre Verwendung zur Herstellung von Arzneimitteln
CZ289298A3 (cs) * 1997-10-14 1999-05-12 Bayer Aktiengesellschaft Způsob výroby pentafluorpentanolu
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6198497B1 (en) 1998-06-03 2001-03-06 Hewlett-Packard Adjustment of a laser diode output power compensator
AU1967300A (en) * 1998-11-20 2000-06-13 Akzo Nobel N.V. Estrogenic estra-1,3,5(10)-trienes with differential effects on the alpha and beta estrogen receptors, having a linear hydrocarbon chain of from 5-9 carbon atoms in position 11
GB0025221D0 (en) 2000-10-14 2000-11-29 Astrazeneca Ab New process
GB0123961D0 (en) 2001-10-05 2001-11-28 Astrazeneca Ab Process and intermediates
US20040235791A1 (en) * 2002-01-25 2004-11-25 Gruskin Elliott A. Scar reduction
DE102008061722A1 (de) 2008-12-12 2010-06-17 Saltigo Gmbh Verfahren zur Herstellung von Perfluoralkyl- oder Perfluoralkoxyalkanolen
KR20220033458A (ko) * 2020-09-09 2022-03-16 주식회사 엘지화학 알킬-d-알라니네이트의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2377419A1 (fr) * 1977-01-13 1978-08-11 Roussel Uclaf Nouveaux derives steroides 11b-substitues 1,3,5 (10) trieniques, leur procede de preparation et leur application comme medicament
FR2528434B1 (fr) * 1982-06-11 1985-07-19 Roussel Uclaf Nouveaux 19-nor steroides substitues en 11b et eventuellement en 2, leur procede de preparation et leur application comme medicament
FR2618783B1 (fr) * 1987-07-30 1991-02-01 Roussel Uclaf Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant
DE3838779A1 (de) * 1988-11-11 1990-05-17 Schering Ag 14(alpha),17(alpha)-ethano-estratriene
DE3925507A1 (de) * 1989-07-28 1991-01-31 Schering Ag 14,17(alpha)-etheno- und ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
RU2087479C1 (ru) * 1989-11-29 1997-08-20 Шеринг Аг Эстратриены, содержащие мостик

Also Published As

Publication number Publication date
EP0642529A1 (de) 1995-03-15
EP0642529B1 (de) 1996-12-11
JPH07501792A (ja) 1995-02-23
DE4132182A1 (de) 1993-03-25
DE59207687D1 (de) 1997-01-23
ES2097924T3 (es) 1997-04-16
GR3022692T3 (en) 1997-05-31
EP0546591A3 (enExample) 1994-03-09
US5502046A (en) 1996-03-26
ATE146185T1 (de) 1996-12-15
DK0642529T3 (da) 1997-06-02
EP0546591A2 (de) 1993-06-16
WO1993006124A1 (de) 1993-04-01

Similar Documents

Publication Publication Date Title
US7018994B2 (en) 17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, USE OF THE 17α-ALKYL-17β-OXY-ESTRATRIENES FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS AS WELL AS PHARMACEUTICAL PREPARATIONS
DE19635525A1 (de) 7alpha-(xi-Aminoalkyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha(xi-Aminoalkyl-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
US5866560A (en) 7α-(ξ-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(ξ-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents
NZ515482A (en) Steroid compounds with a C17-alkyl side chain and an aromatic A-ring for use in therapy
IE851284L (en) 1,24-dihydroxy-delta(22)-vitamin d3
CA2119780A1 (en) 11.beta.-substituted 14,17-ethanoestratrienes, process for preparing these compounds and their use for preparing medicaments
US6288051B1 (en) 7 α-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7 α(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents
JPS6013796A (ja) １−アルキル−アンドロスタ−１，４−ジエン−３，１７−ジオン、その製法及び該化合物を含有するエストロゲン生合成を阻害する製薬的製剤
HU188923B (en) Process for preparing 19-mercapto-androstane derivatives
EP1599493B1 (de) Antitumor wirksame 2-substituierte estra-1,3,5(10)-trien-3-yl sulfamate
EP0318490B1 (de) 14,17-g(b)-ETHANO-14-g(b)-ESTRATRIENE, VERFAHREN ZU DEREN HERSTELLUNG UND DIESE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE
JP2003513102A (ja) 選択的な作用を有するエストロゲンとしての１８−ノル−ステロイド
AU642150B2 (en) 14,17alpha-etheno- and -ethanoestratrienes, processes for the preparation of these compounds, as well as their use for the production of medicinal agents
US6596713B1 (en) Steroid esters and amides, process for their production and their pharmaceutical use
US6670347B2 (en) 19-nor-17α-pregna-1,3,5(10)-trien-17β-ols with a 21,16α-lactone ring
CA2359218A1 (en) 14.beta., 17-alpha-hydroxymethylandrostane derivatives as androgens
AU2004202428B2 (en) 17alpha-alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations
SK2442003A3 (en) 4-Halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
HK1079215B (en) 17α-ALKYL-17β-OXY-ESTRATRIENES, USES THEREOF AND PHARMACEUTICAL PREPARATIONS
DE19954105A1 (de) 18-Nor-Steroide als selektiv wirksame Estrogene
WO2003080642A1 (de) 11beta-substituierte 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ole mit einem 21,16alpha-laktonring
HK1077832B (en) 17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATES FOR THE FRODUCTION THEREOF, AND USE OF SAID 17α-ALKYL-17β-OXY-ESTRATRIENES FOR PRODUCING MEDICAMENTS AND PHARMACEUTICAL PREPARATIONS
AU2004201405A1 (en) Ent-Steroids as selectively active estrogens
HK1012007A1 (en) Bile acid sulfurated derivatives
HK1012007B (en) Bile acid sulfurated derivatives

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued